Insider · CIK 0001298332

Emmens Matthew

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001298332

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+574.212 sh	$63.13	+$36.3K	26,998.916
2021-02-01	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+3,054.171 sh	$62.21	+$190K	26,424.704
2020-12-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+584.395 sh	$62.03	+$36.3K	23,187.894
2020-09-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+601.261 sh	$60.29	+$36.3K	22,433.803
2020-06-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+616.497 sh	$58.80	+$36.3K	21,667.561
2020-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+650.341 sh	$55.74	+$36.3K	20,895.03
2020-02-01	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+3,018.268 sh	$62.95	+$190K	20,244.689
2019-12-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+564.73 sh	$64.19	+$36.3K	17,105.355
2019-09-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+714.849 sh	$50.71	+$36.2K	16,422.827
2019-06-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+767.536 sh	$45.35	+$34.8K	15,566.776
2019-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+681.199 sh	$47.71	+$32.5K	14,670.112
2019-02-01	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+3,708.158 sh	$49.89	+$185K	13,988.913
2018-12-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+625.24 sh	$51.98	+$32.5K	10,064.256
2018-09-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+523.518 sh	$62.08	+$32.5K	9,439.016
2018-06-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+587.279 sh	$55.34	+$32.5K	8,915.498
2018-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+513.834 sh	$63.25	+$32.5K	8,265.47
2018-02-01	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+2,945.86 sh	$62.80	+$185K	7,751.636
2017-12-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+530.352 sh	$61.28	+$32.5K	4,775.359
2017-09-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+509.884 sh	$63.74	+$32.5K	4,218.54
2017-06-30	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+537.423 sh	$55.72	+$29.9K	3,683.031
2017-03-31	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+199.217 sh	$54.38	+$10.8K	3,123.971
2017-02-21	BMYBRISTOL MYERS SQUIBB CO · Deferred Share UnitsA Award	Director	AAward	+2,924.754 sh	$54.78	+$160K	2,924.754
2012-11-16	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−10.9K sh	$41.76	−$453K	200,873
2012-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2012-02-02	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+47.2K sh	$0.01	+$472.01	267,601
2012-02-02	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+236K sh	—	—	236,000
2011-07-13	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+118K sh	—	—	118,000
2011-05-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−9,735 sh	$55.51	−$540K	220,400
2011-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−2,500 sh	$36.39	−$91K	265,101
2011-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−12.9K sh	$37.11	−$479K	252,201
2011-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−40.6K sh	$38.08	−$1.55M	211,601
2011-02-03	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+47.2K sh	$0.01	+$472.01	229,406
2011-02-03	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+236K sh	—	—	236,000
2010-07-14	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+118K sh	—	—	118,000
2010-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+47.2K sh	$0.01	+$472.01	182,205
2010-02-04	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionsA Award	Director	AAward	+354K sh	—	—	354,000
2009-02-05	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	Director	AAward	+134K sh	$0.01	+$1,341.29	134,129
2009-02-05	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+549K sh	—	—	549,000
2008-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2007-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2006-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+20K sh	—	—	50,000
2005-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+10K sh	—	—	30,000

Recent filings

Accepted (ET)
Apr 24
Emmens Matthew0000014272-21-000119
SEC(opens sec.gov)
Feb 34
Emmens Matthew0000014272-21-000049
SEC(opens sec.gov)
Jan 54
Emmens Matthew0000014272-21-000019
SEC(opens sec.gov)
Oct 24
Emmens Matthew0000014272-20-000267
SEC(opens sec.gov)
Jul 24
Emmens Matthew0000014272-20-000212
SEC(opens sec.gov)
Apr 24
Emmens Matthew0000014272-20-000144
SEC(opens sec.gov)
Feb 44
Emmens Matthew0000014272-20-000061
SEC(opens sec.gov)
Jan 34
Emmens Matthew0000014272-20-000017
SEC(opens sec.gov)
Oct 24
Emmens Matthew0000014272-19-000176
SEC(opens sec.gov)
Jul 24
Emmens Matthew0000014272-19-000140
SEC(opens sec.gov)
Apr 24
Emmens Matthew0000014272-19-000094
SEC(opens sec.gov)
Feb 54
Emmens Matthew0000014272-19-000032
SEC(opens sec.gov)
Jan 34
Emmens Matthew0000014272-19-000012
SEC(opens sec.gov)
Oct 24
Emmens Matthew0000014272-18-000187
SEC(opens sec.gov)
Jul 34
Emmens Matthew0000014272-18-000152
SEC(opens sec.gov)
Apr 34
Emmens Matthew0000014272-18-000101
SEC(opens sec.gov)
Feb 54
Emmens Matthew0000014272-18-000044
SEC(opens sec.gov)
Jan 34
Emmens Matthew0000014272-18-000020
SEC(opens sec.gov)
Oct 34
Emmens Matthew0000014272-17-000186
SEC(opens sec.gov)
Jul 54
BRISTOL MYERS SQUIBB CO0000014272-17-000154
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET

CAMBRIDGE, MA, 02139